« Back to Record
Asselah, T., Ferenci, P., Yu, Y., Redman, R., Pilot-Matias, T., Mobashery, N., Hezode, C., Qaqish, R. R., Elkhashab, M., Hassanein, T., Papatheodoridis, G., Feld, J. J., Moreno, C., & Zeuzem, S. (2016). Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial. The Lancet Gastroenterology and Hepatology, 1(1), 25-35. doi:10.1016/S2468-1253(16)30001-2
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/243071



